Based on an assessment of latest clinical facts revealed from the National Institutes of Wellbeing, there's no definitive proof to suggest that Hormone Substitute Therapy (HRT) is an impartial danger variable for prostate cancer. The article also states that HRT is an acceptable therapeutic choice for Adult men with symptomatic hypogonadism (minima